Adam Svobodník
- Pathology and Forensic Medicine top 10%
- Spine and Intervertebral Disc Pathology 2
- Hematology top 10%
- Multiple Myeloma Research and Treatments 4
-
- Immunotherapy and Immune Responses 2
-
- Cancer Risks and Factors 2
-
- Cephalopods and Marine Biology 2
-
- Cervical and Thoracic Myelopathy 2
-
- Respiratory Support and Mechanisms 2
-
- Laser Applications in Dentistry and Medicine 2
- Co-authors
- Pavel BaršaPavel BuchvaldPetr SuchomelLadislav DušekJiří VorlíčekTomáš BüchlerRoman HájekMarta Krejčí
- Partner nations
- CzechiaUnited KingdomUnited States
In The Last Decade
Adam Svobodník
24 papers receiving 382 citations
Peers
Comparison fields: 5 of 72
- Pathology and Forensic Medicine 143
- Hematology 72
- Immunology 72
- Oncology 91
- Rheumatology 38
Countries citing papers authored by Adam Svobodník
This map shows the geographic impact of Adam Svobodník's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Svobodník with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Svobodník more than expected).
Fields of papers citing papers by Adam Svobodník
This network shows the impact of papers produced by Adam Svobodník. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Svobodník. The network helps show where Adam Svobodník may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Adam Svobodník, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 1 | |
| 5 | 2023 | 2 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 15 | |
| 8 | Radiographic progression of rheumatoid arthritis in patients from the Czech National Registry receiving infliximab treatment. | 2008 | 14 |
| 9 | [Acute situation in the National Program of Breast Cancer Screening in the Czech Republic]. | 2007 | 1 |
| 10 | 2005 | 9 | |
| 11 | 2005 | 32 | |
| 12 | 2004 | 91 | |
| 13 | 2004 | 3 | |
| 14 | 2004 | 33 | |
| 15 | 2004 | 19 | |
| 16 | 2004 | 15 | |
| 17 | [Multiple-level instrumented anterior cervical fusion: a risk factor for pseudoarthrosis? A prospective study with a minimum of 3-year follow-up]. | 2004 | 4 |
| 18 | 2003 | 14 | |
| 19 | A realistic view of the treatment of non-small cell lung cancer(NSCLC): an analysis of 348 consecutive patients | 2001 | 1 |
| 20 | Factors delaying hospital admission in acute stroke | 2001 | 15 |
About Adam Svobodník
Adam Svobodník is a scholar working on Critical Care and Intensive Care Medicine, Oncology and Hematology, having authored 29 papers that have together received 395 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (4 papers), Cancer Risks and Factors (2 papers), Cephalopods and Marine Biology (2 papers), Cervical and Thoracic Myelopathy (2 papers), Respiratory Support and Mechanisms (2 papers), Immunotherapy and Immune Responses (2 papers), Spine and Intervertebral Disc Pathology (2 papers) and Laser Applications in Dentistry and Medicine (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (143 citations), Hematology (72 citations) and Immunology (72 citations). Adam Svobodník has collaborated with scholars based in Czechia, United Kingdom and United States. Frequent co-authors include Pavel Barša, Pavel Buchvald, Petr Suchomel, Ladislav Dušek, Jiří Vorlíček, Tomáš Büchler, Roman Hájek, Marta Krejčí, Jiřı́ Mayer and Marcela Vlková. Their work appears in journals such as Scientific Reports, Vaccine and Photochemistry and Photobiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.